Episode Details

Researchers at the University of Connecticut and Jackson Laboratory are testing a new micropatch in clinical trials, which painlessly extracts immune cells and biomarkers from the skin. The patch, made from FDA-approved seaweed material, could revolutionize disease predictions and personalized treatments, especially for aging populations. The trial, called Skin Immunity as a Function of Frailty, Aging, and Skin Microbiome Composition, is funded by the National Institutes of Health and is recruiting diverse participants aged twenty to forty and sixty or older.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/5762e77992e30058